Product Information
AMOXICILLIN 250 MG TAB CHEW is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3044 per EA under NDC 00093226801. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 22, 1992.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093226801
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLINApproval Type
Generic (ANDA)
FDA Application
ANDA064013FDA Approved
12/22/1992
On Market Since
1/1/1993
Pharmacological Classes
Price Statistics
The NADAC for AMOXICILLIN 250 MG TAB CHEW has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3044 per EA |
|---|---|
| All-time high | $0.3422 (Nov 16, 2016) |
| All-time low | $0.1953 (Nov 28, 2013) |
| 52-week high | $0.3147 |
| 52-week low | $0.2905 |
| Median price | $0.2851 |
| Average price | $0.2801 |
| Largest weekly change | +20.1% (Oct 15, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amoxicillin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOXICILLIN 250 MG TAB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for AMOXICILLIN 250 MG TAB CHEW, manufactured by Teva Pharmaceuticals USA Inc., is $0.3044 per EA (NDC 00093226801), effective Sep 30, 2026.
How has the price of AMOXICILLIN 250 MG TAB CHEW changed over time?
Over the history we have for it, the NADAC for AMOXICILLIN 250 MG TAB CHEW has risen 55.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMOXICILLIN 250 MG TAB CHEW?
Since Nov 28, 2013, the NADAC for AMOXICILLIN 250 MG TAB CHEW has ranged from a low of $0.1953 (Nov 28, 2013) to a high of $0.3422 (Nov 16, 2016), with a median of $0.2851 per EA.
Are there cheaper alternatives to AMOXICILLIN 250 MG TAB CHEW?
No other NADAC-published product currently shares the active ingredient and strength of AMOXICILLIN 250 MG TAB CHEW in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMOXICILLIN 250 MG TAB CHEW?
AMOXICILLIN 250 MG TAB CHEW (NDC 00093226801) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.